Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales.

Djennad A, Ramsay ME, Pebody R, Fry NK, Sheppard C, Ladhani SN, Andrews NJ.

EClinicalMedicine. 2019 Jan 2;6:42-50. doi: 10.1016/j.eclinm.2018.12.007. eCollection 2018 Dec.

2.

Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa.

Groome MJ, Tate JE, Arnold M, Chitnis M, Cox S, de Vos C, Kirsten M, le Grange SM, Loveland J, Machaea S, Maharaj A, Andrews N, Madhi SA, Parashar UD.

Clin Infect Dis. 2019 May 24. pii: ciz431. doi: 10.1093/cid/ciz431. [Epub ahead of print]

PMID:
31125061
3.

National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.

Carvalho CFA, Andrews N, Dabrera G, Ribeiro S, Stowe J, Ramsay M, Amirthalingam G.

Clin Infect Dis. 2019 May 6. pii: ciz199. doi: 10.1093/cid/ciz199. [Epub ahead of print]

PMID:
31059566
4.

The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations.

Vekemans J, Crofts J, Baker CJ, Goldblatt D, Heath PT, Madhi SA, Le Doare K, Andrews N, Pollard AJ, Saha SK, Schrag SJ, Smith PG, Kaslow DC.

Vaccine. 2019 May 27;37(24):3190-3198. doi: 10.1016/j.vaccine.2019.04.039. Epub 2019 Apr 25. Review.

5.

Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine.

Godi A, Panwar K, Haque M, Cocuzza CE, Andrews N, Southern J, Turner P, Miller E, Beddows S.

Vaccine. 2019 Apr 24;37(18):2455-2462. doi: 10.1016/j.vaccine.2019.03.052. Epub 2019 Mar 27.

PMID:
30926298
6.

Oral fluid testing facilitates understanding of hepatitis A virus household transmission.

Haywood B, Tedder RS, Beebeejaun K, Balogun K, Mandal S, Andrews N, Ngui SL.

Epidemiol Infect. 2019 Jan;147:e105. doi: 10.1017/S095026881900027X.

7.

Serological surveillance of influenza in an English sentinel network: pilot study protocol.

de Lusignan S, Borrow R, Tripathy M, Linley E, Zambon M, Hoschler K, Ferreira F, Andrews N, Yonova I, Hriskova M, Rafi I, Pebody R.

BMJ Open. 2019 Mar 8;9(3):e024285. doi: 10.1136/bmjopen-2018-024285.

8.

Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment.

Tracey I, Woolf CJ, Andrews NA.

Neuron. 2019 Mar 6;101(5):783-800. doi: 10.1016/j.neuron.2019.02.019. Review.

PMID:
30844399
9.

Serocorrelates of protection against infant group B streptococcus disease.

Le Doare K, Kampmann B, Vekemans J, Heath PT, Goldblatt D, Nahm MH, Baker C, Edwards MS, Kwatra G, Andrews N, Madhi SA, Ter Meulen AS, Anderson AS, Corsaro B, Fischer P, Gorringe A.

Lancet Infect Dis. 2019 May;19(5):e162-e171. doi: 10.1016/S1473-3099(18)30659-5. Epub 2019 Jan 22. Review.

PMID:
30683467
10.

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.

Findlow H, Campbell H, Lucidarme J, Andrews N, Linley E, Ladhani S, Borrow R.

Euro Surveill. 2019 Jan;24(1). doi: 10.2807/1560-7917.ES.2019.24.1.1700818.

11.

Solid peripheral tumor leads to systemic inflammation, astrocyte activation and signs of behavioral despair in mice.

Demers M, Suidan GL, Andrews N, Martinod K, Cabral JE, Wagner DD.

PLoS One. 2018 Nov 15;13(11):e0207241. doi: 10.1371/journal.pone.0207241. eCollection 2018.

12.

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Cronin SJF, Seehus C, Weidinger A, Talbot S, Reissig S, Seifert M, Pierson Y, McNeill E, Longhi MS, Turnes BL, Kreslavsky T, Kogler M, Hoffmann D, Ticevic M, da Luz Scheffer D, Tortola L, Cikes D, Jais A, Rangachari M, Rao S, Paolino M, Novatchkova M, Aichinger M, Barrett L, Latremoliere A, Wirnsberger G, Lametschwandtner G, Busslinger M, Zicha S, Latini A, Robson SC, Waisman A, Andrews N, Costigan M, Channon KM, Weiss G, Kozlov AV, Tebbe M, Johnsson K, Woolf CJ, Penninger JM.

Nature. 2018 Nov;563(7732):564-568. doi: 10.1038/s41586-018-0701-2. Epub 2018 Nov 7.

13.

The use of quasi-experimental designs for vaccine evaluation.

Lopez Bernal JA, Andrews N, Amirthalingam G.

Clin Infect Dis. 2018 Oct 22. doi: 10.1093/cid/ciy906. [Epub ahead of print]

PMID:
30346524
14.

Neural blastocyst complementation enables mouse forebrain organogenesis.

Chang AN, Liang Z, Dai HQ, Chapdelaine-Williams AM, Andrews N, Bronson RT, Schwer B, Alt FW.

Nature. 2018 Nov;563(7729):126-130. doi: 10.1038/s41586-018-0586-0. Epub 2018 Oct 10.

PMID:
30305734
15.

Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17.

Pebody RG, Warburton F, Andrews N, Sinnathamby M, Yonova I, Reynolds A, Robertson C, Cottrell S, Sartaj M, Gunson R, Donati M, Moore C, Ellis J, de Lusignan S, McMenamin J, Zambon M.

Euro Surveill. 2018 Sep;23(39). doi: 10.2807/1560-7917.ES.2018.23.39.1800092.

16.

Inequalities in childhood vaccination timing and completion in London.

Tiley KS, White JM, Andrews N, Ramsay M, Edelstein M.

Vaccine. 2018 Oct 29;36(45):6726-6735. doi: 10.1016/j.vaccine.2018.09.032. Epub 2018 Sep 25.

PMID:
30266484
17.

Diltiazem Promotes Regenerative Axon Growth.

Huebner EA, Budel S, Jiang Z, Omura T, Ho TS, Barrett L, Merkel JS, Pereira LM, Andrews NA, Wang X, Singh B, Kapur K, Costigan M, Strittmatter SM, Woolf CJ.

Mol Neurobiol. 2019 Jun;56(6):3948-3957. doi: 10.1007/s12035-018-1349-5. Epub 2018 Sep 19.

PMID:
30232777
18.

Review of vaccination in pregnancy to prevent pertussis in early infancy.

Campbell H, Gupta S, Dolan GP, Kapadia SJ, Kumar Singh A, Andrews N, Amirthalingam G.

J Med Microbiol. 2018 Oct;67(10):1426-1456. doi: 10.1099/jmm.0.000829. Epub 2018 Sep 17. Review.

PMID:
30222536
19.

Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16.

Pebody RG, Sinnathamby MA, Warburton F, Andrews N, Boddington NL, Zhao H, Yonova I, Ellis J, Tessier E, Donati M, Elliot AJ, Hughes HE, Pathirannehelage S, Byford R, Smith GE, de Lusignan S, Zambon M.

Euro Surveill. 2018 Jun;23(25). doi: 10.2807/1560-7917.ES.2018.23.25.1700496.

20.

Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patients.

Sieberg CB, Taras C, Gomaa A, Nickerson C, Wong C, Ward C, Baskozos G, Bennett DLH, Ramirez JD, Themistocleous AC, Rice ASC, Shillo PR, Tesfaye S, Edwards RR, Andrews NA, Berde C, Costigan M.

Pain Rep. 2018 May 24;3(3):e651. doi: 10.1097/PR9.0000000000000651. eCollection 2018 May.

21.

Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.

De Smedt T, Merrall E, Macina D, Perez-Vilar S, Andrews N, Bollaerts K.

PLoS One. 2018 Jun 15;13(6):e0199180. doi: 10.1371/journal.pone.0199180. eCollection 2018.

22.

Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.

Makwana A, Sheppard C, Borrow R, Fry N, Andrews NJ, Ladhani SN.

Pediatr Infect Dis J. 2018 Jul;37(7):697-703. doi: 10.1097/INF.0000000000001845.

PMID:
29889811
23.

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.

Southern J, Andrews N, Sandu P, Sheppard CL, Waight PA, Fry NK, Van Hoek AJ, Miller E.

PLoS One. 2018 May 25;13(5):e0195799. doi: 10.1371/journal.pone.0195799. eCollection 2018.

24.

Up-Down Reader: An Open Source Program for Efficiently Processing 50% von Frey Thresholds.

Gonzalez-Cano R, Boivin B, Bullock D, Cornelissen L, Andrews N, Costigan M.

Front Pharmacol. 2018 May 1;9:433. doi: 10.3389/fphar.2018.00433. eCollection 2018.

25.

Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme.

Warrener L, Bwogi J, Andrews N, Samuel D, Kabaliisa T, Bukenya H, Brown K, Roper MH, Featherstone DA, Brown D.

Epidemiol Infect. 2018 Jul;146(9):1151-1156. doi: 10.1017/S0950268818000948. Epub 2018 May 9.

PMID:
29739482
26.

Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).

Höschler K, Southern J, Thompson C, Warburton F, Andrews NJ, Miller E, Zambon M.

Vaccine. 2018 May 17;36(21):3034-3040. doi: 10.1016/j.vaccine.2018.04.017. Epub 2018 Apr 19.

PMID:
29680198
27.

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.

Tedder RS, Samuel D, Dicks S, Scott JT, Ijaz S, Smith CC, Adaken C, Cole C, Baker S, Edwards T, Kamara P, Kargbo O, Niazi S, Nwakanma D, d'Alessandro U, Burch G, Doughty H, Brown CS, Andrews N, Glynn JR, van Griensven J; Ebola_CP Consortium Investigators, Pollakis G, Paxton WA, Semple MG.

Transfusion. 2018 May;58(5):1289-1298. doi: 10.1111/trf.14580. Epub 2018 Mar 23.

28.

Effectiveness of herpes zoster vaccination in an older United Kingdom population.

Walker JL, Andrews NJ, Amirthalingam G, Forbes H, Langan SM, Thomas SL.

Vaccine. 2018 Apr 19;36(17):2371-2377. doi: 10.1016/j.vaccine.2018.02.021. Epub 2018 Mar 17.

29.

Varicella zoster virus transmission dynamics in Vojvodina, Serbia.

Medić S, Katsilieris M, Lozanov-Crvenković Z, Siettos CI, Petrović V, Milošević V, Brkić S, Andrews N, Ubavić M, Anastassopoulou C.

PLoS One. 2018 Mar 5;13(3):e0193838. doi: 10.1371/journal.pone.0193838. eCollection 2018.

30.

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.

Thorrington D, Andrews N, Stowe J, Miller E, van Hoek AJ.

BMC Med. 2018 Feb 8;16(1):13. doi: 10.1186/s12916-018-1004-z.

31.

Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling.

Cobos EJ, Nickerson CA, Gao F, Chandran V, Bravo-Caparrós I, González-Cano R, Riva P, Andrews NA, Latremoliere A, Seehus CR, Perazzoli G, Nieto FR, Joller N, Painter MW, Ma CHE, Omura T, Chesler EJ, Geschwind DH, Coppola G, Rangachari M, Woolf CJ, Costigan M.

Cell Rep. 2018 Jan 30;22(5):1301-1312. doi: 10.1016/j.celrep.2018.01.006.

32.

Growing evidence supports 4CMenB effectiveness.

Ladhani SN, Borrow R, Andrews NJ.

Lancet Infect Dis. 2018 Apr;18(4):370-371. doi: 10.1016/S1473-3099(18)30051-3. Epub 2018 Jan 19. No abstract available.

PMID:
29371069
33.

Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.

Oligbu G, Collins S, Andrews N, Sheppard CL, Fry NK, Slack MPE, Borrow R, Ladhani SN.

Clin Infect Dis. 2017 Oct 1;65(7):1191-1198. doi: 10.1093/cid/cix418.

PMID:
29309553
34.

Rigor and reproducibility in rodent behavioral research.

Gulinello M, Mitchell HA, Chang Q, Timothy O'Brien W, Zhou Z, Abel T, Wang L, Corbin JG, Veeraragavan S, Samaco RC, Andrews NA, Fagiolini M, Cole TB, Burbacher TM, Crawley JN.

Neurobiol Learn Mem. 2018 Jan 4. pii: S1074-7427(18)30001-7. doi: 10.1016/j.nlm.2018.01.001. [Epub ahead of print]

PMID:
29307548
35.

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study.

Amirthalingam G, Andrews N, Keel P, Mullett D, Correa A, de Lusignan S, Ramsay M.

Lancet Public Health. 2018 Feb;3(2):e82-e90. doi: 10.1016/S2468-2667(17)30234-7. Epub 2017 Dec 22.

36.

Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?

Leite A, Thomas SL, Andrews NJ.

Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):25-29. doi: 10.1002/pds.4356. Epub 2017 Nov 28.

37.

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.

Goldblatt D, Southern J, Andrews NJ, Burbidge P, Partington J, Roalfe L, Valente Pinto M, Thalasselis V, Plested E, Richardson H, Snape MD, Miller E.

Lancet Infect Dis. 2018 Feb;18(2):171-179. doi: 10.1016/S1473-3099(17)30654-0. Epub 2017 Nov 22.

38.

End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.

Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Gallagher N, Sinnathamby M, Yonova I, Correa A, Moore C, Sartaj M, de Lusignan S, McMenamin J, Zambon M.

Euro Surveill. 2017 Nov;22(44). doi: 10.2807/1560-7917.ES.2017.22.44.17-00306.

39.

Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).

Leite A, Thomas SL, Andrews NJ.

Vaccine. 2017 Dec 14;35(49 Pt B):6885-6892. doi: 10.1016/j.vaccine.2017.09.022. Epub 2017 Oct 19.

40.

Hospitalisation of preterm infants with pertussis in the context of a maternal vaccination programme in England.

Byrne L, Campbell H, Andrews N, Ribeiro S, Amirthalingam G.

Arch Dis Child. 2018 Mar;103(3):224-229. doi: 10.1136/archdischild-2016-311802. Epub 2017 Aug 16.

PMID:
28814424
41.

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016.

Campbell H, Edelstein M, Andrews N, Borrow R, Ramsay M, Ladhani S.

Emerg Infect Dis. 2017 Jul;23(7):1184-1187. doi: 10.3201/eid2307.170236. Epub 2017 Jul 15.

42.

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females.

Haskins-Coulter T, Southern J, Andrews N, Miller E.

Hum Vaccin Immunother. 2017 Jun 3;13(6):1-9. doi: 10.1080/21645515.2016.1277846. Epub 2017 Mar 20.

43.

No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in England.

Andrews N, Stowe J, Miller E.

Vaccine. 2017 Mar 23;35(13):1729-1732. doi: 10.1016/j.vaccine.2017.01.076. Epub 2017 Feb 27.

PMID:
28245941
44.

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.

Venkatesan S, Myles PR, Leonardi-Bee J, Muthuri SG, Al Masri M, Andrews N, Bantar C, Dubnov-Raz G, Gérardin P, Koay ESC, Loh TP, Memish Z, Miller E, Oliva ME, Rath BA, Schweiger B, Tang JW, Tran D, Vidmar T, Waight PA, Nguyen-Van-Tam JS.

Clin Infect Dis. 2017 May 15;64(10):1328-1334. doi: 10.1093/cid/cix127.

45.

Hepatitis E risks: pigs or blood-that is the question.

Tedder RS, Ijaz S, Kitchen A, Ushiro-Lumb I, Tettmar KI, Hewitt P, Andrews N.

Transfusion. 2017 Feb;57(2):267-272. doi: 10.1111/trf.13976.

PMID:
28194857
46.

Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season.

Pebody R, Sile B, Warburton F, Sinnathamby M, Tsang C, Zhao H, Ellis J, Andrews N.

Euro Surveill. 2017 Jan 26;22(4). pii: 30450. doi: 10.2807/1560-7917.ES.2017.22.4.30450.

47.

Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).

Leite A, Andrews NJ, Thomas SL.

Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):437-445. doi: 10.1002/pds.4173. Epub 2017 Feb 3.

48.

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.

Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, White JM, Borrow R, Ramsay ME, Ladhani SN.

Lancet. 2016 Dec 3;388(10061):2775-2782. doi: 10.1016/S0140-6736(16)31921-3. Epub 2016 Oct 27.

PMID:
28100432
49.

Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years.

Southern J, Waight PA, Andrews N, Miller E.

Vaccine. 2017 Jan 23;35(4):619-625. doi: 10.1016/j.vaccine.2016.12.017. Epub 2016 Dec 23.

PMID:
28017441
50.

Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.

Thomas SL, Walker JL, Fenty J, Atkins KE, Elliot AJ, Hughes HE, Stowe J, Ladhani S, Andrews NJ.

Vaccine. 2017 Jan 23;35(4):680-686. doi: 10.1016/j.vaccine.2016.11.057. Epub 2016 Dec 20.

Supplemental Content

Loading ...
Support Center